Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE: 603168)
Health Care · Pharmaceuticals · CN
CN¥5.58
+0.36% today · -30.7% 1Y
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE: 603168) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $310.55M and employs 1,142 people.
Over the last twelve months the share price has lost 30.7%, trading between 4.55 and 9.09.
Tweenvest scores Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. across four factors: quality 56/100, value 53/100, growth 0/100. Its strongest factor is quality.
603168 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $310.55M
- Revenue (TTM)
- $66.63M
- P/E
- —
- EPS
- -0.77
- Dividend yield
- —
- Beta (5Y)
- 0.12
- 52-week high
- CN¥9.09
- 52-week low
- CN¥4.55
- Avg volume (3M)
- —
- Shares outstanding
- 374.13M
- Employees
- 1,142
- Next earnings
- —
About Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.
- ISIN
- CNE100001TG0
- Founded
- 2000
- Listed since
- Jul 2, 2014
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.